M’Balu Webb
I’m a scientist with experience across multiple areas of diabetes research. My PhD and postdoctoral work focused on clinical islet transplantation, after which I spent six years as a Research Scientist/Laboratory Manager within the Leicester Diabetes Centre (LDC). During this time, I contributed to several research projects, including investigations into the role of depression as a risk factor for type 2 diabetes (T2D). After a seven-year period away from research, I recently re-joined the LDC as a Research Associate, where I am now focusing on early-onset type 2 diabetes (EOT2DM) while continuing work exploring the relationship between depression and T2D.
Favourite way to be active
Walking, gardening with a smattering of weight lifting
Contact
maw68@leicester.ac.uk
Research Areas
Early Onset Type 2 Diabetes
Type 2 Diabetes
Depression
Endothelial Progenitor Cells
Pancreatic islets
Current Projects
Part of the M3 study team, assessing the impact of a holistic multifactorial management intervention in adults with early-onset type 2 diabetes
Depression and the risk of type 2 diabetes
Publications
Ahmad E, Waller HL, Sargeant JA, Webb MA, Htike ZZ, McCann GP, Gulsin G, Khunti K, Yates T, Henson J, Davies MJ, Webb DR. Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial. Diabetes Obes Metab. 2021 Jun;23(6):1409-1414. doi: 10.1111/dom.14343. Epub 2021 Feb 26. PMID: 33565691.
Webb DR, Htike ZZ, Swarbrick DJ, Brady EM, Gray LJ, Biglands J, Gulsin GS, Henson J, Khunti K, McCann GP, Waller HL, Webb MA, Sargeant JA, Yates T, Zaccardi F, Davies MJ. A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes. Diabetes Obes Metab. 2020 Jul;22(7):1187-1196. doi: 10.1111/dom.14023. Epub 2020 Apr 1. PMID: 32157772.